Home|Journals|Articles by Year|Audio Abstracts

Review Article

J App Pharm Sci. 2020; 10(7): 155-166

Pediatric dosage forms—challenges and recent developments: A critical review

Amol Dattatreya Galande, Naveen Ahuja Khurana, Srinivas Mutalik.

Cited by 27 Articles

A pediatric population is a diverse group comprising of different subgroups. The use of unlicensed and off-label medicines for treating children is widespread due to the non-availability of suitable dosage forms for this age group. Although physiological differences related to the diverse age group remains an important consideration, various other challenges like insufficient background information on drug molecule, excipient safety, taste masking issues, technology requirements, low profitability, limitations in conduct of clinical trials and lack of regulatory clarity are also important factors affecting pediatric dosage forms development adversely. These factors are discussed in this review. Liquids are the most preferred dosage forms for children, especially of lower age. However, in the absence of suitable or labelled dosage forms, physicians and caretakers are left with no choice but to use off-label, ‘specials’ or extemporaneously prepared formulations. All such non-standard formulations are devoid of relevant scientific data and hence pose a high risk to pediatric patients. The situation is even more serious with developing countries where health care guidelines and controls for pediatric patients scarcely exist. Though in recent past safe, effective and labelled dosage forms are increasingly becoming available, pediatric development still struggles to find the place in the mainstream pharmaceutical development programs.

Key words: Pediatric population; pediatric formulations; excipients for pediatric formulations; taste masking; pediatric drug delivery

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.